Bruker Corporation (Nasdaq: BRKR) has acquired the DISQVER® clinical metagenomics platform from Noscendo GmbH, adding metagenomic next-generation sequencing (mNGS) capabilities ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE